Table 3.
Variable | Adjusted HR* (95% CI) | Adjusted HR** (95% CI) |
---|---|---|
Asthma |
1.13 (1.07-1.19)‡ |
1.40 (1.33-1.48)‡ |
Female |
reference |
reference |
Male |
1.16 (1.11-1.22)‡ |
1.16(1.10-1.22)‡ |
Age group |
|
|
18-29 |
reference |
reference |
30-39 |
1.51 (1.30-1.76)‡ |
1.52 (1.31-1.77)‡ |
40-49 |
1.91 (1.66-2.19)‡ |
1.99 (1.73-2.28)‡ |
50-59 |
2.02 (1.76-2.31)‡ |
2.14 (1.86-2.45)‡ |
≥60 |
2.08 (1.83-2.38)‡ |
2.23 (1.96-2.55)‡ |
Co-morbidity |
|
|
Diabetes |
1.42 (1.33-1.51)‡ |
1.42 (1.33-1.52)‡ |
Hypertension |
15.52 (14.18-16.99)‡ |
15.24 (13.92-16.68)‡ |
Hyperlipidemia |
1.55 (1.45-1.65)‡ |
1.53 (1.43-1.64)‡ |
Heart Disease |
1.84 (1.71-1.98)‡ |
1.92 (1.78-2.06)‡ |
Obesity |
1.3 (1.07-1.58)† |
1.39 (1.14-1.69)‡ |
Medication |
|
|
Steroid (used in 56.2% asthma subjects) | 0.50(0.47-0.53)‡ |
Note: †p < 0.05 for comparison between patients with asthma and without asthma; ‡p < 0.001 for comparison between patients with asthma and without asthma.
HR*, each variable was adjusted for every other variable listed except for medication.
HR**, each variable was adjusted for every other variable listed.